Sociodemographic disparities in sodium-glucose cotransporter-2 inhibitor use among US kidney transplant recipients: An observational study of real-world pharmacy records.
Krista L LentineKana N MiyataNgan N LamCorey JosephMara Ann McAdams-DeMarcoSunjae BaeYusi ChenYasar CaliskanNagaraju SarabuSandeep DhindsaHuiling XiaoDorry L SegevDavid A AxelrodMark A SchnitzlerPublished in: Clinical transplantation (2024)
SGLT2i use is increasing in KTx recipients but varies with factors including race, education, and insurance. While ongoing study is needed to define risks and benefits of SGLT2i use in KTx patients, attention should also focus on reducing treatment disparities related to sociodemographic traits.